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ABSTRACT
Telomere length/DNA content has been measured in
epidemiological/clinical settings with the goal of
testing a host of hypotheses related to the biology
of human aging, but often the conclusions of these
studies have been inconsistent. These inconsisten-
cies may stem from various reasons, including the
use of different telomere length measurement tech-
niques. Here, we report the first impartial evaluation
of measurements of leukocyte telomere length by
Southern blot of the terminal restriction fragments
and quantitative PCR (qPCR) of telomere DNA
content, expressed as the ratio of telomeric product
(T)/single copy gene (S) product. Blind measure-
ments on the same samples from 50 donors were
performed in two independent laboratories on two
different occasions. Both the qPCR and Southern
blots displayed highly reproducible results as shown
by r values> 0.9 for the correlations between results
obtained by either method on two occasions. The
inter-assay CV measurement for the qPCR was
6.45%, while that of the Southern blots was 1.74%.
The relation between the results generated by
Southern blots versus those generated by qPCR
deviated from linearity. We discuss the ramifications
of these findings with regard to measurements of
telomere length/DNA content in epidemiological/
clinical circumstances.
INTRODUCTION
Many independent studies have related telomere length in
human cells (as most commonly measured in peripheral
leukocytes) to risks, incidence and mortality for a variety
of diseases. However, these studies variously use one of
three different methods to assess telomere length proper-
ties: Southern blotting (1), quantitative PCR (qPCR) (2,3)
or flow-FISH (4). The Southern blot analysis of the length
of the terminal restriction fragments (TRFs) of chromo-
somes measures [in kilobases (kb) or nucleotides (nt)] the
mean length and length distributions of not only the ca-
nonical telomeric region (strictly TTAGGG repeats).
However, it also adds in the non-canonical region of the
telomeres up to the nearest restriction site that is the target
of a given set of enzymes used to fragment the DNA prior
to Southern blot analysis (1). In contrast, the qPCR (2,3)
and Flow-fluorescence in situ hybridization (FISH) (4)
techniques measure only the canonical component of telo-
meres. While the qPCR method ‘normalizes’ the quantity
of telomere product to a single gene to provide a mean
telomere length for the cell population, the FISH method
quantifies the telomere florescence signal by using cells of
known telomere length as controls, and can provide infor-
mation on the distribution of telomeric DNA content in a
cell population.
Because each of these three methods employs different
laboratory-based tools and methodologies and, further-
more, generates distinct telomere parameters, comparisons
between studies have often been difficult. Moreover, current
telomere length measurement methods require expertise,
which is not uniform across laboratories, and this can
further complicate the interpretation and comparison of
different studies. For instance, the reported measurement
error of telomere length or DNA content, expressed in the
inter-assay coefficient of variation (CV), has ranged from
2.27% to 28% for the qPCR method that measures
telomere DNA content (5–8) and from 1.5% to 12% for
the Southern blot analysis of the mean length of the TRFs
(9,10). When reported, the inter-assay CV of telomere
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signal by FISH amounts to >5% (11–13). However, none
of the reported ‘low’ CV of telomere length measurements
by various methods has been impartially verified.
The central aim of this report was to compare the inter-
assay CV of telomere length/DNA content, measured on
two occasions by Southern blots of the TRFs or by qPCR.
The FISH method requires intact nuclei and prompt pro-
cessing of samples. For this reason, in epidemiological
research, the Southern blot analysis and qPCR methods,
which are the focus of this impartial evaluation, have been
typically used rather than FISH. In addition, we discuss
several other relevant features of the two methods and
their potential ramifications for epidemiological and
other research.
MATERIALS AND METHODS
Overall design
Two laboratories independently measured telomere length
by Southern blot analysis of the TRFs (Aviv’s Lab) or
telomere DNA content by qPCR (Blackburn’s Lab).
These measurements of leukocyte telomere length (LTL)
were performed on 50 blinded DNA samples from white
donors, ages 41–70 (mean 55.3 9.6), BMI 21–35 (mean
27.9 3.5) and 50% women, whose blood was collected
from 2004 to 2008. DNA was extracted by QIAamp DNA
blood kits in Hunt’s Lab.
Two sets of aliquots were prepared in Hunt’s Lab from
these samples. The two sets had different randomly
assigned ID numbers. The first set was shipped in
parallel to Blackburn’s lab and Aviv’s Lab. The second
set was shipped approximately 2 months later only after
LTL measurements for the first set had been completed
and results transmitted electronically to Hunt for statistic-
al analysis. In this way, both labs ‘blindly’ performed the
telomere length/DNA content measurements on two
occasions.
Telomere DNA content by qPCR
The telomere length measurement assay was adapted from
the published original method by Cawthon (2,3). The
telomere thermal cycling profile consisted of: Cycling for
T (telomeric) PCR: denature at 96C for 1 s, anneal at
54C for 60 s, with fluorescence data collection, 30
cycles. Cycling for S (single copy gene) PCR: denature
at 95C for 15 s, anneal at 58C for 1 s, extend at 72C
for 20 s, eight cycles; followed by denature at 96C for 1 s,
anneal at 58C for 1 s, extend at 72C for 20 s, hold at
83C for 5 s with data collection, 35 cycles.
The primers for the telomere PCR were tel1b [50-CGGT
TT(GTTTGG)5GTT-3
0], used at a final concentration of
100 nM, and tel2b [50-GGCTTG(CCTTAC)5CCT-30],
used at a final concentration of 900 nM. The primers for
the single-copy gene (human beta-globin) PCR were hbg1
[50 GCTTCTGACACAACTGTGTTCACTAGC-30],
used at a final concentration of 300 nM, and hbg2 [50-C
ACCAACTTCATCCACGTTCACC-30], used at a final
concentration of 700 nM.The final reaction mix contained
20mM Tris–HCl, pH 8.4; 50mM KCl; 200 mM each
dNTP; 1% DMSO; 0.4 Syber Green I; 22 ng
Escherichia coli DNA per reaction; 0.4U of Platinum
Taq DNA polymerase (Invitrogen Inc.) per 11 ml reaction;
0.5–10 ng of genomic DNA. Tubes containing 26, 8.75,
2.9, 0.97, 0.324 and 0.108 ng of a reference DNA (from
Hela cancer cells) were included in each PCR run so that
the quantity of targeted templates in each sample was
determined relative to the reference DNA sample by the
standard curve method. Each concentration of the refer-
ence DNA was run as quadruplets and samples were run
as triplicates.
To control for inter-assay variability, eight control
DNA samples from cancer cell lines were included in
each run. The cell lines included 293T, H1299, UMUC3
and UMUC3 cells infected with a lentiviral construct con-
taining the telomerase RNA gene to extend telomeres har-
vested at various population doublings after infection. In
each assay batch, the T/S ratio of each control DNA was
divided by the average T/S for the same DNA from 10
runs to obtain a normalizing factor. This was done for all
eight samples and the average normalizing factor for all
eight samples was used to correct the participant DNA
samples to obtain the final T/S ratio.
The T/S ratio for each sample was measured twice. In
this procedure, when the duplicate T/S value and the
initial value varied by >7%, the sample was run a third
time and the average of two closest values was reported.
Typically, in cohorts from human clinical studies, 15%
of samples have needed to be assayed the third time.
Telomere length measurement by Southern blot analysis
of the TRFs
This measurement was performed as described previously
(1). First DNA integrity was evaluated by SYBR Green I,
after resolving each sample (10 ng) on 1% agarose gel at
200 V for 60min. Second, samples were digested with re-
striction enzymes Hinf I (10U) and Rsa I (10U; Roche).
This cocktail is commonly used in epidemiological studies
to generate the TRFs. Digested DNA samples (3mg each),
and DNA ladders (1-kb DNA ladder plus  DNA/Hind
III fragments; Invitrogen, Carlsbad, CA) were resolved on
0.5% agarose gels. After 16 h, the DNA was depurinated
for 15min in 0.25N HCl, denatured 30min in 0.5M
NaOH/1.5mol/l NaCl and neutralized for 30min in
0.5mol/l Tris, pH 8/1.5M NaCl. The DNA was trans-
ferred for 1 h to a positively charged nylon membrane
(Roche) using a vacuum blotter (Boeckel Scientific,
Feasterville, PA). Membranes were hybridized at 65C
with the DIG labeled telomeric probe overnight in 5
SSC, 0.1% Sarkosyl, 0.02% SDS and 1% blocking
reagent (Roche). They were washed three times at room
temperature in 2 SSC, 0.1% SDS each for 15min and
once in 2 SSC for 15min. The DIG-labeled probe was
detected by the DIG luminescent (Roche) and exposed on
X-ray film. All autoradiographs were scanned, and the
TRF signal was digitized. The optical density values versus
DNA migration distances were converted to optical dens-
ity (adjusted for background)/molecular weight versus
molecular weight [for more details, see (1)]. Each set of
samples was run on duplicates resolved on different gels.
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To compute the mean TRF length, we used the follow-
ing equation:
Mean TRF length ¼ ðODi

=

OD
i
=Li

,
where ODi=optical density at position i and Li is TRF
length at position i.
Statistical analysis
Coefficients of variation were calculated for the duplicate
samples from each of the 50 subjects for each method
using the pooled standard deviation of the duplicates div-
ided by the overall mean of the 100 measurements. Linear
regression was used to estimate the r between the two
methods and to estimate the slopes of LTL with age. A
quadratic term was included in the linear models to test
whether or not the relationship between results generated
by the two methods was linear. No a priori assumptions
were made regarding the behavior of the curve beyond the
data points.
RESULTS
Figure 1 displays correlations between the means of the
replicates of the LTL measurements for the 50 samples in
the second versus the first set of measurements (qPCR
results, Figure 1A; Southern blot results of mean TRF
length, Figure 1B). Clearly, both the qPCR and Southern
blots display highly reproducible results, as expressed in
r> 0.9. On the two occasions, the inter-assay CV meas-
urement for the qPCR was 6.45%, while that of the
Southern blots was 1.74% (Figure 1C).
Figure 2 displays the relation between the mean TRF
length versus the T/S ratio. The Figure 2A shows the
linear regression of this relation. However, a quadratic
term that was added to the linear model was statistically
significant (P=0.003) (Figure 2B). The adjusted R2 for
the model improved slightly from 0.703 to 0.748. Figure 3
shows the age-dependency of telomere lengths across the
age range of the donors based on results generated by the
qPCR (Figure 3A) and those generated by the Southern
blot method (Figure 3B). Age explained 17.2% of the
inter-individual variation in the T/S ratio and 29% of
the inter-individual variation in the mean TRF length.
DISCUSSION
To our knowledge, this is the first study that has com-
pared, as impartially as possible, measurements of LTL
by qPCR versus Southern blot analysis in two laboratories
with considerable experience in performing these two
methods. In comparing the methods one must balance pre-
cision and other features of a given telomere length meas-
urement method with its practicality.
It is important to point out that the pre-analytical
factors that impact the Southern Blot analysis and
qPCR for telomere length measurement could be very dif-
ferent. Whereas the integrity of genomic DNA is crucial
for Southern blots, it is less critical for qPCR. However,
residual PCR inhibitors that may still be present even after
DNA purification could contribute to variability in qPCR.
The influences of different types of blood collection tubes,
as well as individual donor differences have been observed
in a separate study (J. Lin, J. Cheon, E. Epel and
E. Blackburn, manuscript in preparation). The present
study used DNA samples that have been examined for
their DNA length (lack of detectable low-molecular
weight DNA fragments, as assayed on agarose gels) as a
quality control for sample integrity, but we did not address
pre-analytical conditions, including blood collection and
storage, DNA purification and storage, that might con-
tribute to qPCR variability.
As shown in Figure 1, we observed high correlations
between the two sets of measurements of LTL performed
by either the Southern blots of the TRFs or telomere
DNA content generated by the qPCR. The measurement
error, defined by the inter-assay CV, which on the two
occasions tested here, were 6.45% for the qPCR, and
1.74% for the Southern blots. It is useful to regard this
error in the context of the relation between LTL and age
in the present study, and specifically with respect to epi-
demiological research and ultimately clinical practice.
The larger error of the qPCR relative to the Southern
blots could explain the findings that age, across 30 years,
Figure 1. Correlations between the first set of LTL measurements and second set of measurements by qPCR (A) and Southern blot analysis (B) and
the inter-assay variation 95% confidence interval of the two methods (C).
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accounts for 17.2% of the inter-individual variation in the
mean T/S (qPCR method), while it explains 29% of this
variation in the mean TRF length (Southern blot method)
(Figure 3). Thus, we suggest that measurement error
should be a primary consideration, as well as any unique
demographic or biological features, in large-scale cross-
sectional studies that show little or no LTL shortening
over a wide age range.
As an illustrative example, consider an adult whose
LTL=6kb. Measurement errors of 2 and 6% of 6 kb
amount to 120 and 360 nt, respectively. Although the
average rate of LTL shortening in adults is highly
variable, in cross-sectional studies it on average amounts
to 30 nt/year, as also shown in Figure 3. In equivalence
of age-dependent LTL attrition, the error of the measure-
ment by the Southern blot amounts to 4 years, while that
of the qPCR amounts to 13 years. However, it is also im-
portant to note that the rate of LTL change over time has
been shown in longitudinal studies to have a strong de-
pendence upon baseline LTL, and thus base-line TL
should also be co-varied in longitudinal analyses of telo-
mere shortening (14–16). Thus, in cross-sectional studies
the shortening rate is only inferred indirectly based on
group analysis, and masks the findings that the rate of
LTL shortening in individual adults measured longitudin-
ally is highly variable.
In addition, age-dependent LTL attrition is only one
component of LTL dynamics; the other component is
birth LTL. The range of inter-individual variation in
LTL in adults after age adjustment, in cross-sectional
studies, is3–4 kb, and an important contributor to this
variation might be not only the rate of age-dependent LTL
shortening during adult life, but the variation in LTL
across newborns, which is 4–6 kb (11,17–19). Another
significant contributor to LTL in adults is likely to be
the rate of telomere attrition in the period from birth to
early adulthood, which is much higher than that seen in
adults in both humans (11,17,20) and non-human primates
(21). Given this wide inter-individual variation in LTL, a
6% error in telomere length measurement might be ac-
ceptable in epidemiological research and clinical practice,
if the goal of LTL measurement is not to determine the
rate of LTL shortening but to rank individuals for suscep-
tibility to a given disease based on having relatively short,
average or long telomeres for their age.
Figure 2 displays deviation from linearity of the rela-
tion between the mean length of the TRFs and the T/S
ratio, which was observed in other studies (2,22,23).
Figure 2. Linear (A) and curvilinear (B) models depicting the relation between the mean TRF length and the T/S ratio.
Figure 3. Cross sectional analysis of age-dependent telomere shortening based on the qPCR (A) and Southern blots (B).
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The addition of a quadratic term increased the fit of the
data to the regression line. No deviation from linearity is
observed between the mean TRFs and telomere DNA
content generated by a non-PCR method of the strictly
canonical telomeric repeats region of telomeres, suggesting
that this phenomenon is PCR mediated (23).
It is important to regard the ramifications of this work
within the broader framework of epidemiology and
clinical practice. Precision alone might not always justify
the use of Southern blot method of the TRFs, since it is
labor-intensive, costly, requires a large amount of DNA,
cannot be performed in DNA that is even modestly
degraded and requires expertise that might be available
only in a few laboratories (1). Furthermore, while the
qPCR method measures strictly the canonical region of
telomeres, the TRF length data include long stretches of
the non-canonical region, which might be variable across
the general population due to polymorphism in the restric-
tion sites that are the targets of the enzymes generating the
TRFs.
Epidemiologists have employed various methods to
measure telomere length but there has been less discussion
of the shortcomings of the methods used. Moreover,
measurements errors of the same method often differ
among laboratories. Therefore, the findings of the
present study by two laboratories with considerable ex-
perience in qPCR and Southern blots might not represent
those generated in less experienced laboratories. For these
reasons, large-scale epidemiological studies comparing the
Southern blot analysis versus qPCR and possibly other
methods (measured in a number of laboratories for each
method) will bolster understanding of aging-related
maladies and gage the risk of developing them. This will
more fully address matters related to the question: which
is the optimal method to measure telomere length?
Without such studies, identifying the optimal method for
assessing telomere length unbiased by preconceived views
will be hampered.
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